Related Experiment Video
Updated: Aug 16, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
Cyclooxygenase-2 expression increases with the stage and grade in transitional cell carcinoma of the urinary bladder
Pankaj Wadhwa1, Anil K Goswami, Kusum Joshi
1Department of Urology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Objectives:
Experimental models of carcinogenesis show that non-steroidal anti-inflammatory drugs (NSAIDs) increase apoptosis, inhibit angiogenesis and reduce metastases. A linkage between the activity of prostaglandin synthase enzyme cyclooxygenase-2 (COX-2), a known mediator of inflammation, and cancer angiogenesis is implicated. We investigated the expression of COX-2 in bladder cancer tissue specimens using immunohistochemistry.
Methods:
The immunohistochemical expression of COX-2 in bladder cancer was evaluated by scoring the intensity of immunoreactivity from 0 to 3. Further, the degree of COX-2 expression was correlated with the tumor grade and depth of invasion (T stage).
Result:
Fifty eight percent patients (n=22) had superficial bladder tumors, while 42% (n=16) were invasive bladder cancers. Overall, COX-2 immuno-positivity was seen in 84.2% (32/38) patients. COX-2 expression was positive in 76.4% (13/17) cases with pTa tumors, 100% (5/5) of pT1 tumors, 86.6% (13/15) of pT2 tumors and in 100% (1/1) of pT3 tumor. The higher stage tumors stained more intensely; this correlation was significant(p=0.01987; chi2=19.6977). With reference to the grade of tumors, a positive expression was seen in 81.25% (13/16) of the low-grade tumors and 89% (17/19) of the high-grade tumors. The differential COX-2 expression relative to the grade of tumor was found to be statistically significant (p=0.05; chi2=15.8612).
Conclusion:
The degree of COX-2 expression is significantly increased with advancing grade and T stage of disease (p < 0.05).
Insights
Cyclooxygenase-2 (COX-2) is highly expressed in bladder cancer, with increased expression correlating significantly with higher tumor grade and stage. This suggests COX-2 may play a role in bladder cancer progression.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Non-steroidal anti-inflammatory drugs (NSAIDs) show anti-cancer effects in experimental models by increasing apoptosis, inhibiting angiogenesis, and reducing metastasis.
- Cyclooxygenase-2 (COX-2), a mediator of inflammation, is implicated in cancer angiogenesis.
Purpose of the Study:
- To investigate the expression of cyclooxygenase-2 (COX-2) in bladder cancer tissue specimens.
- To correlate COX-2 expression levels with tumor grade and depth of invasion (T stage).
Main Methods:
- Immunohistochemistry was used to evaluate COX-2 expression in bladder cancer tissues.
- Immunoreactivity for COX-2 was scored from 0 to 3.
- Statistical analysis was performed to correlate COX-2 expression with tumor grade and T stage.
Main Results:
- COX-2 immuno-positivity was observed in 84.2% of the 38 bladder cancer patients studied.
- COX-2 expression intensity significantly correlated with advancing tumor T stage (p=0.01987).
- A statistically significant correlation was found between COX-2 expression and tumor grade (p=0.05).
Conclusions:
- The degree of COX-2 expression is significantly elevated in bladder cancer.
- Increased COX-2 expression is associated with higher tumor grade and advanced T stage.
- These findings suggest a role for COX-2 in bladder cancer progression.
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
